2023 Bernice Grafstein Lecture in Neuroscience presents Dr. Marina Picciotto
The Integrated Program in Neuroscience (IPN) invites Dr. Marina Picciotto is give the 2023 Bernice Grafstein Lecture in Neuroscience. Dr. Picciotto is the Charles B. G. Murphy Professor of Psychiatry and Professor in the Child Study Center, of Neuroscience and of Pharmacology at Yale School of Medicine. Her talk is entitled “A novel VTA GABA pathway that encodes unconditioned reward value”. Dr.
March Neurogenesis talks explore brain mechanisms in food choice and computational modelling
Last week, HBHL hosted the third talk of the 2024-2025 Neurogenesis Speaker Series at the Neuro, featuring Dana Small and Yashar Zeighami.
AI analysis of healthcare records reveals key factors in autism diagnosis
Scientists argue the criteria we use for diagnosing autism may need revisionWithout clear and effective biological tests for autism based on genes, brain or blood measurements, diagnosis today still largely depends on clinical assessment. The standard way of doing this is by observing how the individual fits the criteria for autism listed in gold standard manuals like the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).
Expanding access to specialized healthcare across Quebec: ECHO Superhub at The Neuro
Free, online training program strengthens training and brings specialized care to communities across QuebecA healthcare telementoring program housed at The Neuro and supported by the Transforming Autism Care Consortium (TACC) is expanding its reach after achieving designation as an ECHO Superhub.
Latest Alzheimer’s drug shown less effective in females than males
Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD in the last quarter of 2024.
Genetic sequencing project receives more than $8 million in funding
NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians
A project led by Ziv Gan-Or, MD, PhD, at The Neuro (Montreal Neurological Institute-Hospital) of McGill University and Martine Tétreault, PhD, at Université de Montréal has received more than $8 million to sequence the genomes of 8,700 people, to map the role of genetics in neurological disorders.
Project to create AI model for ALS receives Génome Québec funding
$400,000 will fuel public-private collaboration to discover new disease biomarkers
Achievements of clinicians and scientists recognized with King Charles III Coronation Medals
Five clinicians and scientists at The Neuro have been awarded King Charles III Coronation Medals in recognition of their contributions to our understanding of neurological disease. The Coronation Medal commemorates the Coronation of His Majesty King Charles III as King of Canada. The medal is administered by the Chancellery of Honours at Rideau Hall.
Prescribing anti-swelling drug reduces immune response weeks after last dose
Mapping immune cell diversity reveals dexamethasone’s impact on brain cancer immunotherapy
Swelling caused by brain cancer is a problem that can lead to serious side effects and even death. While controlling swelling is important, a new study shows that a commonly prescribed anti-swelling drug suppresses the immune system for weeks after dosage, inhibiting the body’s ability to fight the cancer.
Six principal investigators from The Neuro receive CIHR grants
Projects include important research on Parkinson’s, glioblastoma and dementia